Technical Analysis for AVTE - Aerovate Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bullish Signal Line Cross | Bullish | 3.44% | |
New 52 Week Closing High | Bullish | 3.44% | |
Expansion Breakout | Bullish Swing Setup | 3.44% | |
Pocket Pivot | Bullish Swing Setup | 3.44% | |
Volume Surge | Other | 3.44% | |
New 52 Week High | Strength | 3.44% | |
Earnings Movers | Other | 3.44% | |
Above Upper BB | Strength | 3.44% | |
Gapped Up | Strength | 3.44% | |
Upper Bollinger Band Touch | Strength | 3.44% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | 39 minutes ago |
Rose Above Previous Day's High | about 1 hour ago |
New 52 Week High | about 1 hour ago |
Up 3% | about 1 hour ago |
Up 2% | about 1 hour ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/27/2024
Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Chemical Compounds Hypertension Orphan Drug Pulmonary Arterial Hypertension Pulmonary Hypertension Imatinib Piperazines
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Chemical Compounds Hypertension Orphan Drug Pulmonary Arterial Hypertension Pulmonary Hypertension Imatinib Piperazines
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 29.36 |
52 Week Low | 9.41 |
Average Volume | 130,279 |
200-Day Moving Average | 17.12 |
50-Day Moving Average | 21.97 |
20-Day Moving Average | 25.24 |
10-Day Moving Average | 26.19 |
Average True Range | 2.36 |
RSI (14) | 63.37 |
ADX | 38.39 |
+DI | 26.09 |
-DI | 11.21 |
Chandelier Exit (Long, 3 ATRs) | 22.29 |
Chandelier Exit (Short, 3 ATRs) | 27.06 |
Upper Bollinger Bands | 28.35 |
Lower Bollinger Band | 22.13 |
Percent B (%b) | 1.02 |
BandWidth | 24.62 |
MACD Line | 1.46 |
MACD Signal Line | 1.41 |
MACD Histogram | 0.053 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 34.11 | ||||
Resistance 3 (R3) | 33.77 | 31.57 | 33.18 | ||
Resistance 2 (R2) | 31.57 | 30.14 | 31.74 | 32.86 | |
Resistance 1 (R1) | 30.03 | 29.26 | 30.80 | 30.37 | 32.55 |
Pivot Point | 27.83 | 27.83 | 28.21 | 28.00 | 27.83 |
Support 1 (S1) | 26.29 | 26.40 | 27.06 | 26.63 | 24.45 |
Support 2 (S2) | 24.09 | 25.52 | 24.26 | 24.14 | |
Support 3 (S3) | 22.55 | 24.09 | 23.83 | ||
Support 4 (S4) | 22.89 |